Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-24

Clinical Trial Update: Efficacy of Phycocyanin and Palmitoylethanolamide for the Treatment of Chronic Prostatitis Symptoms [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of phycocyanin and palmitoylethanolamide for chronic prostatitis symptoms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palmitoylethanolamide (palmitoylethanolamide)
  • Phycocyanin (phycocyanin)

Snippet

Sponsor: Clinica Urologica Molinette - Città della Saliute e della Scienza | Conditions: Chronic Prostatitis (CP), Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Phase 4 | Status: COMPLETED